Literature DB >> 23770304

Molecular and clinical heterogeneity in pyruvate kinase deficiency in India.

Prashant Warang1, Prabhakar Kedar, Kanjaksha Ghosh, Roshan Colah.   

Abstract

We studied the PK-LR gene in 10 unrelated Indian patients with congenital haemolytic anemia associated with erythrocyte pyruvate kinase deficiency. The patients had a variable presentation ranging from a very mild compensated hemolysis to severe anemia. Nine different mutations were detected among the 20 mutated alleles identified: one deletion (c.1042-1044del) p.Lys348del and eight single-nucleotide (nt) substitutions resulting in amino acid exchanges c.397A>G (p.Asn133Asp), c.992A>G (p.Asp331Gly), c.1072G>A (p.Gly358Arg), c.1076G>A (p.Arg359His), c.1219G>A (p.Glu407Lys), c.1241C>T (p.Pro414Leu), c.1436G>A (p.Arg479His) and c.1529G>A (p.Arg510Gln) were identified. Although all the exons, the flanking regions and the promoter region were sequenced in all cases, we failed to detect the second expected mutation in two subjects. Two mutations [c.397A>G; c.1241C>T] were novel. These novel missense mutations involved highly conserved amino acids. Two mutations were identified for the first time in the homozygous state globally (c1042-1044del; c.1072G>A) and two other mutations were identified for the first time in our population (c.1076G>A; c.1529G>A). This study along with our earlier report suggests that the most frequent mutations in India would appear to be c.1436G>A (18.33%), followed by c.992A>G (11.66%) and c.1456C>T (11.66%). Structural implications of amino acid substitutions were correlated with the clinical phenotypes seen.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glycolytic enzymes; Hemolytic anemia; Molecular modeling; Pyruvate kinase; Red cell enzymes

Mesh:

Substances:

Year:  2013        PMID: 23770304     DOI: 10.1016/j.bcmd.2013.05.006

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.

Authors:  Prabhakar S Kedar; Hideo Harigae; Etsuro Ito; Hideki Muramatsu; Seiji Kojima; Yusuke Okuno; Tohru Fujiwara; Rashmi Dongerdiye; Prashant P Warang; Manisha R Madkaikar
Journal:  Int J Hematol       Date:  2019-08-10       Impact factor: 2.490

2.  The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherol.

Authors:  Yeh Chen; Ping-Xiao Lin; Chiu-Lan Hsieh; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

Review 3.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

4.  Novel mutations associated with pyruvate kinase deficiency in Brazil.

Authors:  Maria Carolina Costa Melo Svidnicki; Andrey Santos; Jhonathan Angel Araujo Fernandez; Ana Paula Hitomi Yokoyama; Isis Quezado Magalhães; Vitoria Regia Pereira Pinheiro; Silvia Regina Brandalise; Paulo Augusto Achucarro Silveira; Fernando Ferreira Costa; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2017-11-26

5.  [Identification and characterization of PKLR gene mutation in two patients with erythrocyte pyruvate kinase deficiency].

Authors:  Z D Huang; J Shi; Y Q Shao; N Nie; J Zhang; J B Huang; X X Li; M L Ge; Y Z Zheng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

Review 6.  Iron Deficiency Anemia: Efficacy and Limitations of Nutritional and Comprehensive Mitigation Strategies.

Authors:  Shashi Bhushan Kumar; Shanvanth R Arnipalli; Priyanka Mehta; Silvia Carrau; Ouliana Ziouzenkova
Journal:  Nutrients       Date:  2022-07-20       Impact factor: 6.706

Review 7.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

8.  The variable manifestations of disease in pyruvate kinase deficiency and their management.

Authors:  Hanny Al-Samkari; Eduard J Van Beers; Kevin H M Kuo; Wilma Barcellini; Paola Bianchi; Andreas Glenthøj; María Del Mar Mañú Pereira; Richard Van Wijk; Bertil Glader; Rachael F Grace
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.